Citadel Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,200
Closed -$34.2K 14926
2025
Q1
$34.2K Buy
1,200
+200
+20% +$6.32K ﹤0.01% 12689
2024
Q4
$33K Buy
+1,000
New +$37.7K ﹤0.01% 12782
2024
Q3
Sell
-400
Closed -$13.4K 15251
2024
Q2
$13.4K Sell
400
-300
-43% -$10.1K ﹤0.01% 12942
2024
Q1
$25K Buy
700
+200
+40% +$6.93K ﹤0.01% 12846
2023
Q4
$16.5K Sell
500
-100
-17% -$2.69K ﹤0.01% 12790
2023
Q3
$16.3K Sell
600
-7,700
-93% -$232K ﹤0.01% 12782
2023
Q2
$262K Buy
8,300
+900
+12% +$28K ﹤0.01% 9323
2023
Q1
$201K Buy
7,400
+7,200
+3,600% +$217K ﹤0.01% 10174
2022
Q4
$6.08K Buy
+200
New +$6.02K ﹤0.01% 13946
2022
Q2
Sell
-8,100
Closed -$272K 14115
2022
Q1
$272K Sell
8,100
-200
-2% -$6.93K ﹤0.01% 10804
2021
Q4
$351K Buy
8,300
+200
+2% +$8.91K ﹤0.01% 10561
2021
Q3
$369K Sell
8,100
-1,400
-15% -$64.3K ﹤0.01% 10588
2021
Q2
$465K Sell
9,500
-5,300
-36% -$254K ﹤0.01% 10210
2021
Q1
$744K Buy
14,800
+5,800
+64% +$321K ﹤0.01% 8816
2020
Q4
$461K Sell
9,000
-3,600
-29% -$171K ﹤0.01% 8296
2020
Q3
$518K Sell
12,600
-17,200
-58% -$709K ﹤0.01% 7248
2020
Q2
$1.25M Buy
29,800
+12,400
+71% +$489K ﹤0.01% 5421
2020
Q1
$552K Buy
17,400
+9,100
+110% +$348K ﹤0.01% 6305
2019
Q4
$351K Sell
8,300
-1,600
-16% -$59.4K ﹤0.01% 7343
2019
Q3
$312K Buy
9,900
+1,300
+15% +$45.7K ﹤0.01% 7492
2019
Q2
$311K Buy
8,600
+1,300
+18% +$44.8K ﹤0.01% 7534
2019
Q1
$264K Sell
7,300
-4,000
-35% -$134K ﹤0.01% 7807
2018
Q4
$318K Sell
11,300
-3,900
-26% -$129K ﹤0.01% 7159
2018
Q3
$598K Buy
15,200
+8,600
+130% +$326K ﹤0.01% 6415
2018
Q2
$246K Sell
6,600
-1,600
-20% -$58K ﹤0.01% 7546
2018
Q1
$281K Buy
+8,200
New +$287K ﹤0.01% 6852
2017
Q4
Sell
-7,100
Closed -$221K 8465
2017
Q3
$221K Buy
+7,100
New +$208K ﹤0.01% 6546
2017
Q2
Sell
-8,200
Closed -$211K 8075
2017
Q1
$211K Buy
+8,200
New +$204K ﹤0.01% 6425

Other funds holding SBIO